CPSA Shanghai 2011
Changing Paradigm in Drug Discovery & Development:
East Meets West
April 13 - 16, 2011
Renaissance Shanghai Pudong Hotel
Shanghai, China
Abstract
Thursday AM - Parallel Session III
High-Throughput Bioanalysis Using an Ultra-fast On-line Extraction System
Wenying Jian1, Michelle V. Romm2, Richard W. Edom1, Vaughn P. Miller2, William A. LaMarr2, Naidong Weng1
1. Johnson & Johnson Pharmaceutical Research & Development, Raritan, NJ
2. Agilent Technologies, formerly BIOCIUS Life Sciences, Wakefield, MA
Biomarkers can play an important role at every stage of drug development, from drug discovery to pre-clinical evaluation and to clinical trials. This presentation examines the integrated biomarker services capabilities provide by Covance R&D Laboratories within and outside China. Utilizing a global network of central labs, both clinical development biomarkers as well as exploratory research biomarkers can be incorporated in clinical trials, including oncology trials that often have complex needs for various types of genomics and anatomic pathology biomarkers and genomics services, at regional and global scales.